- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03574961
E-Support Groups in Multiple Sclerosis (eSupport)
A Randomized Controlled Trial of e-Support in Persons With Multiple Sclerosis
Primary objectives:
- To determine the feasibility of program (80% retained with 75% overall attendance, and completed immediate follow-up questionnaires from 75% of participants).
- To determine the efficacy of program (evaluated by decreased loneliness, operationalized as decreased total score on the UCLA Loneliness Scale from pre to post intervention).
Secondary objective:
- To determine whether program will affect depression and quality of life.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study involves prospective data collection from an intervention to investigate the impact of participation by MS patients in a 12-week guided online social support group. All outcomes will be compared to active control group. At the completion of a 12-week interval, all participants (placebo and treatment) will complete follow-up questionnaires. Three months after completing, participants will be sent follow-up questionnaires that will be evaluated as a 6-month follow-up, to assess retention of benefits.
Social support has been linked to better health outcomes in many clinical populations. Multiple sclerosis (MS), a chronic neurological disease that affects over 400,000 people in the United States, involves physical and cognitive disability that can have negative consequences on social integration. This can lead to social isolation, which may be dynamically related to depression, fatigue, and disease progression. The aim of the present study is to investigate the impact of support group involvement on persons with MS. Outcomes of interest include mood, loneliness, and quality of life (QOL). Many people with MS feel isolated and are unable to participate in support groups that meet in locations that may be far from home, difficult to travel to (due to physical disability or lack of resources), or may not be convenient for their schedules. Another hindrance is the apprehension that MS patients sometimes experience when they encounter patients with severe physical disability, or worse impairment than their own. For these reasons, the study is introducing remote support groups to be conducted via the internet, "e-Support." Attending a remote, internet based support group may be more appealing to patients with MS as it obviates the need to travel, thereby reducing cost, time, and energy.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
New York
-
New York, New York, Förenta staterna, 10032
- Columbia University Medical Center (MS Center)
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Diagnosis of MS (any disease type)
- Age 18 or over
- Willingness to sign informed consent document
Exclusion Criteria:
- Unable to obtain access to the internet
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: e-Support Group
Participants in this arm will receive the treatment, 12 weeks of 1-hr weekly moderated e-Support sessions.
|
Online (remote), web-based support group via private video link.
Andra namn:
|
Placebo-jämförare: e-Journaling Placebo
Participants in this arm will complete 12 weeks of 1-hr weekly online journaling activities.
|
Online journaling activity.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Percentage of enrolled participants who completed follow-up questionnaires
Tidsram: 12 weeks
|
Assess feasibility of the program: to retain and obtain completed questionnaires at immediate follow-up from 80% of enrolled participants (meeting the criteria of 75% attendance).
|
12 weeks
|
Change in UCLA Loneliness Scale total score (please note that the official name of the scale is the UCLA Loneliness Scale).
Tidsram: Baseline, 12 weeks (immediate follow-up)
|
Assess efficacy of the program to decrease loneliness as defined by a significant decrease in total score on UCLA Loneliness Scale.
This name never appears as anything other than UCLA Loneliness Scale, i.e.
Russell 1996)
|
Baseline, 12 weeks (immediate follow-up)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in overall depression [Patient Health Questionnaire (PHQ-9)] total score
Tidsram: Baseline, 12 weeks
|
Assess efficacy of the program to decrease depression as defined by a significant decrease in total score on Patient Health Questionnaire (PHQ-9): an efficient tool for depression screening.
The scale ranges from 0-27, with higher scores indicating worse depression.
|
Baseline, 12 weeks
|
Change in overall Functional Assessment of Multiple Sclerosis Quality of Life (FAMS QoL) score
Tidsram: Baseline, 12 weeks
|
Assess efficacy of the program to improve quality of life.
The Functional Assessment of Multiple Sclerosis (FAMS) quality of life (QoL) instrument is a disease-specific, self-report questionnaire.
It includes 7 subscales.
The total score is generated by summing scores across all subscales, and ranges from 0-232, with higher scores reflective or worse overall function.
In addition to considering a significant decrease in the total score as an indication of better overall function, we will separately examine each subscale to see whether decreases in score (indicating improvements in function) are shown.
This includes the following subscales: mobility, symptoms, emotional well-being, general contentment, thinking and fatigue, family/social well-being, and additional concerns scales.
|
Baseline, 12 weeks
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Victoria M Leavitt, PhD, Columbia University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- AAAR4052
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Multipel skleros
-
Centre Hospitalier Universitaire de NīmesAvslutadMonckeberg Medial Calcific SclerosisFrankrike
-
Assistance Publique - Hôpitaux de ParisOkändArteriosclerosis Obliterans | Diabetiska vaskulära sjukdomar | Monckeberg Medial Calcific SclerosisFrankrike
-
City of Hope Medical CenterNational Cancer Institute (NCI)Aktiv, inte rekryterandeKlassiskt Hodgkin lymfom | Lymfocytrikt klassiskt Hodgkin-lymfom | Ann Arbor stadium IB Hodgkin lymfom | Ann Arbor stadium II Hodgkin lymfom | Ann Arbor stadium IIA Hodgkin lymfom | Ann Arbor stadium IIB Hodgkin lymfom | Ann Arbor stadium I Hodgkin lymfom | Ann Arbor Steg I blandad cellularitet Klassiskt... och andra villkorFörenta staterna
Kliniska prövningar på e-Support group
-
Tulane University School of Social WorkUnited States Agency for International Development (USAID)AvslutadSorg | Sörjande
-
Women's College HospitalUniversity Health Network, Toronto; Memorial Sloan Kettering Cancer Center och andra samarbetspartnersAvslutadUterina cervikala neoplasmer | Uterina neoplasmer | Genitala neoplasmer, hona | Ovariella neoplasmer | Sexuella dysfunktioner, psykologiskaKanada, Förenta staterna
-
University of Central FloridaAlzheimer's and Dementia Resource CenterAvslutadDemens | Alzheimers sjukdomFörenta staterna
-
Weill Medical College of Cornell UniversityRekrytering
-
University of ConnecticutNational Institute of Mental Health (NIMH)Avslutad
-
University of VirginiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RekryteringPolycystiskt ovariesyndrom | Typ 2-diabetes mellitus | Insulinresistens | Onormal viktökning | Övervikt | För tidig adrenarcheFörenta staterna
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteAvslutad
-
Women's College HospitalSunnybrook Health Sciences Centre; Centre for Addiction and Mental Health; University of TorontoAvslutad
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)AvslutadHjärtsvikt, kongestivFörenta staterna
-
Dokuz Eylul UniversityHar inte rekryterat ännuPosttraumatiskt stressyndrom (PTSD)